• Welcome to Alif Super Shop

Emparol-M 5/500mg Tablet

(0 reviews)
15.00 Tk

Product Benefits

Core BenefitMechanism
Superior Glycemic ControlCombines the actions of decreasing glucose output/increasing sensitivity (Metformin) with increasing glucose removal via the urine (Dapagliflozin) for potent, complimentary blood sugar lowering.
Proven Cardio-Renal BenefitsDapagliflozin is proven to reduce the risk of hospitalization for heart failure and slow the progression of chronic kidney disease in diabetic patients, offering vital long-term protection.
Modest Weight ReductionThe glucose excretion caused by Dapagliflozin leads to calorie loss, often resulting in modest but beneficial weight reduction.
Low Risk of HypoglycemiaWhen used without insulin or sulfonylureas, the therapy carries a low intrinsic risk of dangerously low blood sugar, as Metformin and Dapagliflozin do not directly stimulate insulin release.

⚠️ Important Safety Note: Dual Component Warnings

  • Prescription Required: This medication must be taken strictly as prescribed.

  • Lactic Acidosis Risk (Metformin): Metformin carries a rare but serious risk of Lactic Acidosis, especially in patients with kidney impairment.11 Seek immediate medical attention if you experience unusual muscle pain, difficulty breathing, or severe stomach pain.

  • Diabetic Ketoacidosis ($\text{DKA}$) Risk (Dapagliflozin): Dapagliflozin can cause 12$\text{DKA}$ even with normal blood sugar levels (euglycemic 13$\text{DKA}$).14 Symptoms include nausea, vomiting, and confusion. Report these immediately.

  • Genital/$\text{UTI}$ Risk: Due to glucose in the urine, Dapagliflozin increases the risk of genital yeast infections and urinary tract infections ($\text{UTIs}$). Maintain strict hygiene and monitor for symptoms.

Customer questions & answers

Info! No reviews available for this product yet.

Customer reviews

0 out of 5
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
Warning! You must be logged in to submit a review. Login